443 related articles for article (PubMed ID: 34774030)
1. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
4. Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma.
Saito K; Arai E; Maekawa K; Ishikawa M; Fujimoto H; Taguchi R; Matsumoto K; Kanai Y; Saito Y
Sci Rep; 2016 Jun; 6():28932. PubMed ID: 27357243
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
7. Lipidomic profiling of non-mineralized dental plaque and biofilm by untargeted UHPLC-QTOF-MS/MS and SWATH acquisition.
Drotleff B; Roth SR; Henkel K; Calderón C; Schlotterbeck J; Neukamm MA; Lämmerhofer M
Anal Bioanal Chem; 2020 Apr; 412(10):2303-2314. PubMed ID: 31942654
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA.
Nizioł J; Bonifay V; Ossoliński K; Ossoliński T; Ossolińska A; Sunner J; Beech I; Arendowski A; Ruman T
Anal Bioanal Chem; 2018 Jun; 410(16):3859-3869. PubMed ID: 29658093
[TBL] [Abstract][Full Text] [Related]
9. Application of Lipidomics for Assessing Tissue Lipid Profiles of Patients With Squamous Cell Carcinoma.
Zeng W; Zheng W; Hu S; Zhang J; Zhang W; Xu J; Yu D; Peng J; Zhang L; Gong M; Wei Y
Technol Cancer Res Treat; 2021; 20():15330338211049903. PubMed ID: 34761720
[No Abstract] [Full Text] [Related]
10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
12. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
13. Single-cell lipidomics with high structural specificity by mass spectrometry.
Li Z; Cheng S; Lin Q; Cao W; Yang J; Zhang M; Shen A; Zhang W; Xia Y; Ma X; Ouyang Z
Nat Commun; 2021 May; 12(1):2869. PubMed ID: 34001877
[TBL] [Abstract][Full Text] [Related]
14. Targeted Lipidomics Analysis of Adipose and Skeletal Muscle Tissues by Multiple Reaction Monitoring Profiling.
Chen X; Ferreira CR; Kuang S
Methods Mol Biol; 2023; 2640():351-368. PubMed ID: 36995607
[TBL] [Abstract][Full Text] [Related]
15. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
16. SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis.
Ma Y; Qi Y; Wang L; Zheng Z; Zhang Y; Zheng J
Free Radic Biol Med; 2019 Apr; 134():458-467. PubMed ID: 30703481
[TBL] [Abstract][Full Text] [Related]
17. MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
Neumann CKA; Silver DJ; Venkateshwari V; Zhang R; Traughber CA; Przybycin C; Bayik D; Smith JD; Lathia JD; Rini BI; Brown JM
Mol Metab; 2020 Apr; 34():136-145. PubMed ID: 32180553
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma.
Wang Z; Guo X; Wang W; Gao L; Bao X; Feng M; Lian W; Zhu H; Xing B
J Clin Endocrinol Metab; 2021 Jan; 106(1):e273-e287. PubMed ID: 33031533
[TBL] [Abstract][Full Text] [Related]
19. Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma.
Choi JM; Kim TE; Cho JY; Lee HJ; Jung BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():157-65. PubMed ID: 24316528
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lipid quantification accuracy using HILIC and RPLC MS on the example of NIST® SRM® 1950 metabolites in human plasma.
Lange M; Fedorova M
Anal Bioanal Chem; 2020 Jun; 412(15):3573-3584. PubMed ID: 32240327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]